Pinnacle Digest

Category: Sponsored Small Cap News

Clinical Director of Imperial College’s Center for Psychedelic Research Joins Entheon Advisory Board

Posted on by Pinnacle Digest
Entheon

Dr. David Erritzoe to provide guidance on psychopharmacological research Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (“Entheon” or the “Company“), a biotechnology company focused on developing psychedelic medicines to treat addiction, is pleased to announce that Dr. David Erritzoe, the current Clinical Director of the Imperial College’s Center for Psychedelic Research, has been […]

Read More…

Entheon Biomedical Corp. Announces DTC Eligibility

Posted on by Pinnacle Digest

Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (“Entheon” or the “Company“), a biotechnology company focused on developing psychedelic medicines to treat addiction, is pleased to announce that its common shares are now eligible for electronic clearing and settlement through the Depository Trust Company (“DTC”) in the United States. The DTC is the largest […]

Read More…

Entheon Biomedical Announces Sponsorship of a Clinical Study to Assess the Electroneurophysiologic Effects of Ketamine

Posted on by Pinnacle Digest
Entheon-DNA

Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (“Entheon” or the “Company“), a biotechnology company focused on developing psychedelic medicines to treat addiction, today announced the sponsorship of a clinical research study with Heading Health LLC (“Heading Health”) as institution and Dr. Steve Levine, MD, as principal investigator to determine the electroneurophysiologic effects of […]

Read More…

Entheon Biomedical Corp. Acquires Lobo Genetics Inc.

Posted on by Pinnacle Digest
DNA molecule - entheon

Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (“Entheon” or the “Company“) is pleased to announce that the Company completed its acquisition of Lobo Genetics Inc. (“Lobo“), a personalized genetics company with a direct-to-consumer platform currently being used in both the psychedelics and cannabis spaces to provide personalized insights into an individual’s response to […]

Read More…

Entheon Biomedical Further Strengthens Advisory Board with Appointment of Dr. Andy Greenshaw

Posted on by Pinnacle Digest
board of directors conference room

Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (“Entheon” or the “Company“), a biotechnology company focused on developing psychedelic medicines to treat addiction, is pleased to announce the addition of Dr. Andrew (Andy) Greenshaw, Professor of Psychiatry and Neuroscience and Associate Chair (Research) for Psychiatry at the University of Alberta. Dr. Greenshaw is a […]

Read More…

New Placer Dome Gold Corp. Outlines 2021 Gold Resource Expansion and New Discovery Program

Posted on by Pinnacle Digest
aerial view of kinsley mountain

New Placer Dome Gold Corp. (” New Placer Dome ” or the ” Company “) (TSX-V: NGLD) (OTCQB: NPDCF) (FSE: BM5) is pleased to announce plans for the 2021 resource expansion and new discovery program at its flagship Kinsley Mountain Gold Project (” Kinsley Mountain “) in Nevada. Building on its successful 2020 campaign, the 2021 Kinsley Mountain exploration program will, subject […]

Read More…

Ares Completes Processing Facility Acquisition

Posted on by Pinnacle Digest
westleaf closes option to purchase cannabis store location on broadway in saskatchewan

Ares Strategic Mining Inc. (“ Ares ” or the “ Company ”) (TSXV:ARS) (OTC:ARSMF) (FRA:N8I1) is pleased to announce that, further to its news releases dated February 26, 2021, the Company has closed its acquisition of a fluorspar lump manufacturing facility (the “ Facility ”) pursuant to the terms and conditions of a Profit Sharing Agreement dated February 9, 2021, as […]

Read More…

Rritual Superfoods Issues Letter to Shareholders

Posted on by Pinnacle Digest
Rritual Superfoods to begin trading on the CSE

Rritual Superfoods Inc. (” Rritual ” or the “Company” ) (CSE: RSF) (FSE: 0RW) (OTCQB: RRSFF) is pleased to provide the following letter to shareholders, outlining the Company’s advancements and increased retail targets, as previously announced, for the Rritual Superfoods product line in the USA . To the Shareholders of Rritual Superfoods: It is with great excitement that I am taking this opportunity to […]

Read More…

Rritual Superfoods Pioneers Plant-Based Collagen Boosters to Create “Beauty from Within”

Posted on by Pinnacle Digest

Rritual Superfoods Inc. (“Rritual” or the “Company”) (CSE: RSF) (FSE: 0RW) (OTC: RRSFF) is pleased to announce that the Company’s Product Innovation and Research team has completed testing on the first of its new superfood mushroom latte blend formulations, incorporating plant-based collagen enhancers as a key market differentiator. In the fall of 2021, Rritual will be introducing two new […]

Read More…

Rritual Superfoods Appoints Tinuiti Digital Agency to Maximize Brand Awareness

Posted on by Pinnacle Digest
rritual superfoods tea steeper

Rritual Superfoods Inc. (“Rritual” or the “Company”) (CSE: RSF) (FSE: 0RW) (OTCQB: RRSFF) is pleased to announce that the Company has appointed Tinuiti as its Digital Advertising Agency. The prioritization of e-commerce is central to Rritual’s growth strategy. Tinuiti provides expertise with their proprietary technology, resulting in a trail blazing and highly responsive approach to building the Rritual […]

Read More…